138 related articles for article (PubMed ID: 33872112)
1. Metastatic Malignant Peritoneal Mesothelioma Mimicking an Autoinflammatory Syndrome in a 12-Year-Old Boy.
Olmedilla G; Undaondo C; Vasquez W; Rodriguez N
Pediatr Dev Pathol; 2021; 24(5):478-483. PubMed ID: 33872112
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal malignant mesothelioma: Slippery like an eel to diagnose on cytology-case series of 3 cases.
Gupta N; Soni A; Mahajan R; Selhi P; Tyagi R; Garg B; Kaur H
J Am Soc Cytopathol; 2022; 11(1):40-45. PubMed ID: 34602383
[TBL] [Abstract][Full Text] [Related]
3. Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child.
Gong YS; Rong YT; Han WC; Zhang YC
Hum Pathol; 2013 Apr; 44(4):664-9. PubMed ID: 23313308
[TBL] [Abstract][Full Text] [Related]
4. The value of BRCA-1-associated protein 1 expression and cyclin-dependent kinase inhibitor 2A deletion to distinguish peritoneal malignant mesothelioma from peritoneal location of carcinoma in effusion cytology specimens.
Althakfi W; Gazzo S; Blanchet M; Isaac S; Piaton E; Villeneuve L; Glehen O; Gilly FN; Brevet M
Cytopathology; 2020 Jan; 31(1):5-11. PubMed ID: 31713897
[TBL] [Abstract][Full Text] [Related]
5. ALK positive malignant peritoneal mesothelioma mimicking inflammatory myofibroblastic tumour: a diagnostic pitfall.
Louw A; Wallace C; Chai SM; Amanuel B; Wong DD
Pathology; 2020 Oct; 52(6):719-722. PubMed ID: 32814620
[No Abstract] [Full Text] [Related]
6. Peritoneal adenomatoid (microcystic) mesothelioma.
Mori D; Kido S; Hiraki M; Sumi K; Ureshino N; Masuda M; Nabeshima K; Akashi M
Pathol Int; 2020 Nov; 70(11):876-880. PubMed ID: 32881200
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Malignant Peritoneal Mesothelioma With Meningeal Metastasis.
Aldrian D; Neu N; Oberhuber G; Kropshofer G; Müller T; Vogel GF
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e272-e274. PubMed ID: 33633025
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal malignant mesothelioma metastatic to supraclavicular lymph nodes.
Zannella S; Testi MA; Cattoretti G; Pelosi G; Zucchini N
Int J Surg Pathol; 2014 Sep; 22(6):552-4. PubMed ID: 24474244
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant.
Shinozaki-Ushiku A; Kohsaka S; Kage H; Oda K; Miyagawa K; Nakajima J; Aburatani H; Mano H; Ushiku T
Pathol Int; 2020 Oct; 70(10):775-780. PubMed ID: 32583627
[TBL] [Abstract][Full Text] [Related]
10. Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology.
Chevrier M; Monaco SE; Jerome JA; Galateau-Salle F; Churg A; Dacic S
Cancer Cytopathol; 2020 Dec; 128(12):939-947. PubMed ID: 32678499
[TBL] [Abstract][Full Text] [Related]
11. Diffuse malignant peritoneal mesothelioma.
Shih CA; Ho SP; Tsay FW; Lai KH; Hsu PI
Kaohsiung J Med Sci; 2013 Nov; 29(11):642-5. PubMed ID: 24183360
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
13. Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.
Chapel DB; Schulte JJ; Absenger G; Attanoos R; Brcic L; Butnor KJ; Chirieac L; Churg A; Galateau-Sallé F; Hiroshima K; Hung YP; Kindler H; Krausz T; Marchevsky A; Mino-Kenudson M; Mueller J; Nabeshima K; Turaga K; Walts AE; Husain AN
Mod Pathol; 2021 Feb; 34(2):380-395. PubMed ID: 33060816
[TBL] [Abstract][Full Text] [Related]
14. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
Sussman J; Rosai J
Am J Surg Pathol; 1990 Sep; 14(9):819-28. PubMed ID: 2389813
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology.
Nasit JG; Dhruva G
Am J Clin Pathol; 2014 Aug; 142(2):233-42. PubMed ID: 25015866
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of malignant retroperitoneal mesothelioma: A case report.
Tang F; Cui Y; Gao Y
Medicine (Baltimore); 2024 Apr; 103(17):e37985. PubMed ID: 38669368
[TBL] [Abstract][Full Text] [Related]
17. [Metastasis revealing malignant peritoneum mesothelioma: About the difficulty to identify the primary tumors].
Bretagne CH; Petitjean A; Felix S; Bedgedjian I; Algros MP; Delabrousse E; Valmary-Degano S;
Ann Pathol; 2016 Apr; 36(2):105-10. PubMed ID: 26993587
[TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis.
Benzerdjeb N; Dartigues P; Kepenekian V; Valmary-Degano S; Mery E; Avérous G; Chevallier A; Laverriere MH; Villa I; Harou O; Sallé FG; Villeneuve L; Glehen O; Isaac S; Hommell-Fontaine J; Bibeau F;
Virchows Arch; 2021 Oct; 479(4):765-772. PubMed ID: 33855595
[TBL] [Abstract][Full Text] [Related]
19. A Rare Case of Biphasic Malignant Peritoneal Mesothelioma with Refractory Ascites.
Komaki T; Urata H; Mori K; Iwashita A; Ikeda K; Haraoka S
Intern Med; 2017; 56(7):861-864. PubMed ID: 28381756
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma.
Krasinskas AM; Borczuk AC; Hartman DJ; Chabot JA; Taub RN; Mogal A; Pingpank J; Bartlett D; Dacic S
Histopathology; 2016 Apr; 68(5):729-37. PubMed ID: 26272336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
